HomeEGTX • STO
add
Egetis Therapeutics AB (publ)
Previous close
kr 4.75
Day range
kr 4.40 - kr 4.63
Year range
kr 4.04 - kr 9.30
Market cap
1.58B SEK
Avg Volume
496.58K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 10.80M | -66.87% |
Operating expense | 113.00M | 110.82% |
Net income | -110.50M | -28.19% |
Net profit margin | -1.02K | -286.94% |
Earnings per share | -0.30 | 0.00% |
EBITDA | -103.60M | -33.33% |
Effective tax rate | -0.36% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 351.00M | 15.73% |
Total assets | 792.30M | 4.22% |
Total liabilities | 299.40M | 39.52% |
Total equity | 492.90M | — |
Shares outstanding | 359.24M | — |
Price to book | 3.47 | — |
Return on assets | -38.14% | — |
Return on capital | -50.32% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -110.50M | -28.19% |
Cash from operations | -53.60M | -28.54% |
Cash from investing | -1.20M | -340.00% |
Cash from financing | 272.80M | 2.98% |
Net change in cash | 221.10M | 1.28% |
Free cash flow | -29.45M | -44.81% |
About
Founded
2006
Website
Employees
40
